User profiles for J.K. Damås
 | Jan Kristian DamåsNTNU Verified email at ntnu.no Cited by 15143 |
Chemokines and cardiovascular risk
…, K Otterdal, L Gullestad, JK Damås - … , and vascular biology, 2008 - Am Heart Assoc
… Hence, although some potential advantages (eg, relatively high serum/plasma levels,
minor influence on freeze/thaw cycles, stable during storage; Aukrust P and Damås JK, …
minor influence on freeze/thaw cycles, stable during storage; Aukrust P and Damås JK, …
Role of inflammation in the progression of heart failure
A Yndestad, JK Damås, E Øie, T Ueland… - Current cardiology …, 2007 - Springer
Chronic heart failure (HF) is a disorder characterized in part by immune activation and
inflammation. Thus, patients with HF have elevated levels of a number of inflammatory cytokines, …
inflammation. Thus, patients with HF have elevated levels of a number of inflammatory cytokines, …
Inflammatory and anti‐inflammatory cytokines in chronic heart failure: potential therapeutic implications
P Aukrust, L Gullestad, T Ueland, JK Damås… - Annals of …, 2005 - Taylor & Francis
Persistent inflammation, involving increased levels of inflammatory cytokines, seems to play
a pathogenic role in chronic heart failure (HF) by influencing heart contractility, inducing …
a pathogenic role in chronic heart failure (HF) by influencing heart contractility, inducing …
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization
…, M Skjelland, E Øie, A Dahl, A Michelsen, JK Damås… - Circulation, 2007 - Am Heart Assoc
Background— Although the participation of inflammation in atherogenesis is widely recognized,
the identification of the different components has not been clarified. In particular, the role …
the identification of the different components has not been clarified. In particular, the role …
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
JW Haukeland, JK Damås, Z Konopski, EM Løberg… - Journal of …, 2006 - Elsevier
BACKGROUND/AIMS: To elucidate the role of systemic inflammation in nonalcoholic fatty
liver disease (NAFLD). METHODS: Serum samples in 47 patients with histologically verified …
liver disease (NAFLD). METHODS: Serum samples in 47 patients with histologically verified …
Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction
Background Prompt myocardial revascularization with percutaneous coronary intervention (PCI)
reduces infarct size and improves outcomes in patients with ST-segment elevation …
reduces infarct size and improves outcomes in patients with ST-segment elevation …
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial …
Aims Interleukin-6 (IL-6) contributes to atherosclerotic plaque destabilization and is involved
in myocardial injury during ischaemia–reperfusion. Interleukin-6 is therefore a potential …
in myocardial injury during ischaemia–reperfusion. Interleukin-6 is therefore a potential …
[HTML][HTML] Poor performance of quick-SOFA (qSOFA) score in predicting severe sepsis and mortality–a prospective study of patients admitted with infection to the …
Background We aimed to evaluate the clinical usefulness of qSOFA as a risk stratification tool
for patients admitted with infection compared to traditional SIRS criteria or our triage system…
for patients admitted with infection compared to traditional SIRS criteria or our triage system…
Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release
Inflammation is associated with development of atherosclerosis, and cholesterol crystals (CC)
have long been recognized as a hallmark of atherosclerotic lesions. CC appear early in …
have long been recognized as a hallmark of atherosclerotic lesions. CC appear early in …
Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study
Chronic obstructive pulmonary disease (COPD) is considered an inflammatory pulmonary
disorder with systemic inflammatory manifestations. The aim of this study was to assess the …
disorder with systemic inflammatory manifestations. The aim of this study was to assess the …